What does CUSIP 69353Y103 represent in this 13F holders report?

CUSIP 69353Y103 is the security identifier for PMVP - PMV Pharmaceuticals, Inc. - COMMON STOCK used to aggregate holder disclosures.

How many institutions held PMVP - PMV Pharmaceuticals, Inc. - COMMON STOCK in Q4 2020?

72 institutional investors reported PMVP - PMV Pharmaceuticals, Inc. - COMMON STOCK for Q4 2020. Use the holders table for investor-level position and value details.

PMV Pharmaceuticals, Inc. - COMMON STOCK (PMVP)

CUSIP: 69353Y103

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class: Equity / COMMON STOCK
Shares outstanding: 53,185,766
Total 13F shares: 38,212,089
Share change: +2,496,465
Total reported value: $2,335,342,669
Price per share: $61.51
Number of holders: 72
Value change: +$185,049,476
Number of buys: 51
Number of sells: 24

Quarterly Holders Quick Answers

What is CUSIP 69353Y103?
CUSIP 69353Y103 identifies PMVP - PMV Pharmaceuticals, Inc. - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2021
Previous quarter: Q3 2020

Recent filing periods for CUSIP 69353Y103:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of PMVP - PMV Pharmaceuticals, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
ORBIMED ADVISORS LLC	13F	Company	14%	7,330,423	$260,230,000	—	30 Sep 2020	13F
INTERWEST VENTURE MANAGEMENT CO	13F	Company	12%	6,469,911	$229,682,000	—	30 Sep 2020	13F
VIKING GLOBAL INVESTORS LP	13F	Company	5%	2,641,840	$93,785,000	—	30 Sep 2020	13F
Boxer Capital, LLC	13F	Company	4.3%	2,268,236	$80,522,000	—	30 Sep 2020	13F
RA CAPITAL MANAGEMENT, L.P.	13F	Company	3.2%	1,710,265	$60,714,000	—	30 Sep 2020	13F
Avoro Capital Advisors LLC	13F	Company	3.5%	1,850,000	$57,578,000	—	30 Sep 2020	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	3.1%	1,645,822	$57,139,000	—	30 Sep 2020	13F
PERCEPTIVE ADVISORS LLC	13F	Company	1.1%	605,556	$21,497,000	—	30 Sep 2020	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	1%	557,843	$19,803,000	—	30 Sep 2020	13F
BlackRock Finance, Inc.	13F	Company	1%	542,038	$19,242,000	—	30 Sep 2020	13F
RTW INVESTMENTS, LP	13F	Company	0.94%	500,000	$17,750,000	—	30 Sep 2020	13F
ALKEON CAPITAL MANAGEMENT LLC	13F	Company	0.89%	475,000	$16,863,000	—	30 Sep 2020	13F
FMR LLC	13F	Company	0.77%	411,200	$14,598,000	—	30 Sep 2020	13F
ArrowMark Colorado Holdings LLC	13F	Company	0.75%	400,000	$14,200,000	—	30 Sep 2020	13F
Invesco Ltd.	13F	Company	0.75%	400,000	$14,200,000	—	30 Sep 2020	13F
JANUS HENDERSON GROUP PLC	13F	Company	0.68%	361,724	$12,841,000	—	30 Sep 2020	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.66%	350,000	$12,425,001	—	30 Sep 2020	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.53%	280,425	$9,955,000	—	30 Sep 2020	13F
FEDERATED HERMES, INC.	13F	Company	0.47%	250,000	$8,875,000	—	30 Sep 2020	13F
DRIEHAUS CAPITAL MANAGEMENT LLC	13F	Company	0.45%	237,563	$8,433,000	—	30 Sep 2020	13F
Woodline Partners LP	13F	Company	0.39%	207,421	$7,363,000	—	30 Sep 2020	13F
PRINCIPAL FINANCIAL GROUP INC	13F	Company	0.38%	200,800	$7,128,000	—	30 Sep 2020	13F
Artal Group S.A.	13F	Company	0.38%	200,000	$7,100,000	—	30 Sep 2020	13F
FRANKLIN RESOURCES INC	13F	Company	0.38%	200,000	$7,100,000	—	30 Sep 2020	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.32%	167,751	$5,955,000	—	30 Sep 2020	13F
Avidity Partners Management LP	13F	Company	0.28%	150,000	$5,325,000	—	30 Sep 2020	13F
JENNISON ASSOCIATES LLC	13F	Company	0.28%	150,000	$5,325,000	—	30 Sep 2020	13F
Logos Global Management LP	13F	Company	0.28%	150,000	$5,325,000	—	30 Sep 2020	13F
OLD MISSION CAPITAL LLC	13F	Company	0.1%	51,700	$1,835,000	—	30 Sep 2020	13F
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	0.09%	50,000	$1,775,000	—	30 Sep 2020	13F
EcoR1 Capital, LLC	13F	Company	0.09%	50,000	$1,775,000	—	30 Sep 2020	13F
Holocene Advisors, LP	13F	Company	0.09%	50,000	$1,775,000	—	30 Sep 2020	13F
Legal & General Group Plc	13F	Company	0.09%	46,300	$1,730,000	—	30 Sep 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.06%	33,000	$1,171,000	—	30 Sep 2020	13F
JANE STREET GROUP, LLC	13F	Company	0.06%	31,349	$1,113,000	—	30 Sep 2020	13F
Pinz Capital Management, LP	13F	Company	0.05%	27,814	$987,000	—	30 Sep 2020	13F
Asymmetry Capital Management, L.P.	13F	Company	0.05%	24,892	$884,000	—	30 Sep 2020	13F
Squarepoint Ops LLC	13F	Company	0.04%	22,156	$787,000	—	30 Sep 2020	13F
VANGUARD GROUP INC	13F	Company	0.04%	20,000	$710,000	—	30 Sep 2020	13F
NORTHERN TRUST CORP	13F	Company	0.03%	15,978	$567,000	—	30 Sep 2020	13F
CITADEL ADVISORS LLC	13F	Company	0.03%	13,375	$475,000	—	30 Sep 2020	13F
Alpine Global Management, LLC	13F	Company	0.02%	11,701	$415,000	—	30 Sep 2020	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.02%	10,763	$382,000	—	30 Sep 2020	13F
JPMORGAN CHASE & CO	13F	Company	0.02%	10,000	$380,000	—	30 Sep 2020	13F
Laurion Capital Management LP	13F	Company	0.02%	10,000	$355,000	—	30 Sep 2020	13F
MORGAN STANLEY	13F	Company	0.01%	6,900	$245,000	—	30 Sep 2020	13F
Point72 Hong Kong Ltd	13F	Company	0.01%	6,291	$223,000	—	30 Sep 2020	13F
Maven Securities LTD	13F	Company	0.01%	5,000	$200,000	—	30 Sep 2020	13F
Sio Capital Management, LLC	13F	Company	0%	1,000	$36,000	—	30 Sep 2020	13F
UBS Group AG	13F	Company	0%	571	$20,000	—	30 Sep 2020	13F

Institutional Holders of PMV Pharmaceuticals, Inc. - COMMON STOCK (PMVP) as of Q4 2020

As of 31 Dec 2020, PMV Pharmaceuticals, Inc. - COMMON STOCK (PMVP) was held by 72 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 38,212,089 shares. The largest 10 holders included ORBIMED ADVISORS LLC, INTERWEST VENTURE MANAGEMENT CO, Euclidean Capital LLC, VIKING GLOBAL INVESTORS LP, Avoro Capital Advisors LLC, BOXER CAPITAL, LLC, RA CAPITAL MANAGEMENT, L.P., BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, and VANGUARD GROUP INC. This page lists 72 institutional shareholders reporting positions in this security for the Q4 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2020 vs Q3 2020 Across Filers

Q3 2020 holders

Q4 2020 holders

Holder diff

Investor	Q3 2020 Shares	Q4 2020 Shares	Share Diff	Share Chg %	Q3 2020 Value $	Q4 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.